Health Condition 1: T630- Toxic effect of snake venom
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (aged =18 years) irrespective of gender and admitted to the hospital with snake bite envenomation and on therapy with ASV.
Exclusion criteria
Exclusion criteria: 1.Patients who were managed with supportive therapy alone 2. Patients referred from other centres with the history of snakebites with concomitant hospital acquired infections. 3.Patients with history of snakebite more than 10 days and referred for further management.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the effectiveness of ASV treatment dosing in terms of recovery/mortality Timepoint: Assessment done at 2 time points: Time of enrollment and at the time of discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of -ventilation -oxygenation -hospitalization days -severity scores -laboratory parameters -weaning of vasopressors Safety would be assessed by monitoring for any adverse reactions due to ASV in patientTimepoint: Assessment done at 2 time points: Time of enrollment and at the time of discharge | — |
Countries
India
Contacts
Public ContactGirish Thunga
Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka
Outcome results
None listed